Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3388111 Title: COMPOSÉ ORGANOARSÉNIQUE POUR LE TRAITEMENT D'UN CANCER

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
181748179
WO application number:
Type:
European patent granted for BE
Status:
Lapsed
Publication number:
3388111
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
14/08/2009
Grant date:
29/09/2021
EP publication date:
17/10/2018
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
29/09/2021
EP B1 publication date:
29/09/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
31/08/2023
Expiration date (if granted and all annual fees paid):
14/08/2029

Applicant

Name:
Solasia Pharma K.K.
Legal Form:
From:
29/09/2021
Address:
4F, Sumitomo Fudosan Shiba-koen Tower 2-11-1 Shiba-koen Minato-ku, Tokyo 105-0011, Japan (JP)
To:

Agent

Name:
DE CLERCQ & PARTNERS C.V.B.A.
Legal Form:
From:
17/11/2021
Address:
Ed. Gevaertdreef 10a, 9830, ST MARTENS LATEM, Belgium (BE)
To:

Inventor

1

Name:
SCHWARTZ, Brian, Eric
Legal Form:
Address:
Woodbridge, CT Connecticut 06525, United States (US)

2

Name:
LEWIS, Jonathan
Legal Form:
Address:
Fairfield, CT Connecticut 06824, United States (US)

3

Name:
KOMARNITSKY, Philip, B.
Legal Form:
Address:
Chestnut Hill, MA Massachusetts 02467, United States (US)

Priority

Priority patent number:
189511 P
Priority date:
20/08/2008
Priority country:
United States (US)

Classification

IPC or IDT classification:
A61P 35/00; A61K 31/455; A61K 38/06; A61K 31/285; A61K 31/60;

Publication

Bulletin

1

Bulletin heading:
EP2
Journal edition number:
2021/18
Publication date:
11/10/2021
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

2

Bulletin heading:
VRV
Journal edition number:
2024/07
Publication date:
06/05/2024
Description:
Contains data concerning lapse, annulment or rejection of patent(s) (applications) and SPC (applications)

European Patent Bulletin

Issue number:
202139
Publication date:
29/09/2021
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
Annual fee number:
Expected payer:
Last annual fee payment date:
17/08/2022
Last annual fee paid number:
14
Last annual fee paid amount:
320 Euro
Payer:
DENNEMEYER & Co S.A.R.L.
Filing date Document type Publication Type Document Description Number of pages File Type
17/11/2021 General Document Declaration of domicile 1 PDF /2/7/8/5/6/0722165872/docs/181748179_0_generaldocument_20211118_084734824.pdf
17/11/2021 Incoming Correspondence (Email) Cover letter 1 PDF /2/7/8/5/6/0722165872/docs/181748179_1_incomingcorrespondenceelectronic_20211118_084735029.pdf
17/11/2021 Outgoing Correspondence 1 PDF /2/7/8/5/6/0722165872/docs/181748179_2_outgoingcorrespondence_20211118_084734598.pdf